EUVIMEDEUVIMED entdecken
Open Access

NDR1 enhances USP9X-mediated AR deubiquitination and promotes enzalutamide resistance in castration-resistant prostate cancer

Zeyuan Zheng, Jinxin Li, Yifan Du, Liyan Li, Qingqing Wu, Bin Liu, Haodong Wu, Zeyi Zhang, Zuodong Xuan, Yue Zhao, Huimin Sun, Chen Shao

International Journal of Biological Sciences · 2025

DOI: 10.7150/ijbs.114686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von Zeyuan Zheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361101, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Phenylthiohydantoin, Ubiquitin Thiolesterase, Receptors, Androgen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantPhenylthiohydantoinUbiquitin ThiolesteraseReceptors, AndrogenMaleNitrilesHumansBenzamidesDrug Resistance, NeoplasmCell Line, TumorAnimalsUbiquitinationMiceMice, Nude

Stichwörter der Autor:innen

ARCastration-resistant prostate cancerEnzalutamide resistanceNDR1USP9X

Substanzen

NitrilesenzalutamidePhenylthiohydantoinUbiquitin ThiolesteraseBenzamidesReceptors, AndrogenUSP9X protein, humanAR protein, human

Autor:innen und Institutionen

  • Department of Urology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361101, China.
  • Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Central Laboratory, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361101, China.

Zitieren

APA

Zheng, Z., Li, J., Du, Y., Li, L., Wu, Q., Liu, B., Wu, H., Zhang, Z., Xuan, Z., Zhao, Y., Sun, H., & Shao, C. (2025). NDR1 enhances USP9X-mediated AR deubiquitination and promotes enzalutamide resistance in castration-resistant prostate cancer. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.114686

Vancouver

Zheng Z, Li J, Du Y, Li L, Wu Q, Liu B, et al. NDR1 enhances USP9X-mediated AR deubiquitination and promotes enzalutamide resistance in castration-resistant prostate cancer. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.114686

BibTeX
@article{Zheng2025,
  author = {Zheng, Zeyuan and Li, Jinxin and Du, Yifan and Li, Liyan and Wu, Qingqing and Liu, Bin and Wu, Haodong and Zhang, Zeyi and Xuan, Zuodong and Zhao, Yue and Sun, Huimin and Shao, Chen},
  title = {NDR1 enhances USP9X-mediated AR deubiquitination and promotes enzalutamide resistance in castration-resistant prostate cancer},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  doi = {10.7150/ijbs.114686}
}
Kostenlos starten →